Nortis is a biotech company with locations in Seattle and Woodinville, WA. Founded by former UW faculty and spun-out in 2011, Nortis has developed technologies for generating small segments of human tissues and organs in microfluidic chips for the in vitro study of human health and disease. Though not officially a UW startup, Nortis was spun out of UW startup VisionGate, and was among the first tenants at the CoMotion Incubator.
More than 250 companies have been started by UW students and faculty or with UW technology
Stella Therapeutics, a privately held drug discovery company, is developing first-in-class small molecules that hold the promise of curing Glioblastoma Multiforme (GBM), the most common and deadliest malignant brain tumor, while maintaining patient quality of life.
C-SATS (Crowd-Sourced Assessment of Technical Skills) offers a performance management system for evaluating and improving technique in healthcare professionals rapidly, accurately and cost effectively.
Vicis has developed a new football helmet designed to mitigate impact forces.
Applied Dexterity’s goal is to advance the field of robotically assisted surgery by creating a research surgical robot that fosters collaboration. Researchers can program and modify the RAVENTM system but it serves as a standard platform so that they can share their software and improvements. RAVEN is designed to be an extensible, robust, and programmable research tool to allow researchers in engineering, surgery, and computer science to experiment, innovate, and collaborate.
NanoSurface Biomedical develops versatile biomimetic cultureware technologies (for culturing cell lines) that allow researchers to more closely mimic the topography of native cellular micro-environments in all of their studies.
Deurion has developed a unique method to perform diagnostics and mass spectrometry, an analytical technique that produces spectra of the masses of atoms or molecules constituting a sample of material.
Stasys is commercializing a novel device to assess the state of blood coagulation in trauma patients within minutes, helping emergency physicians save lives.
Soluxra is a company that develops high performance electro-optic and electronic polymer materials and applies device design expertise to the semiconductor, telecommunications, and clean energy industries.
LodeSpin Labs is creating the next generation of iron oxide nanoparticle tracers for medical imaging, using technology developed by the founders at the University of Washington.
Answerdash has developed contextual Q&A technology that provides website and web application users with instant context-sensitive answers right when and where they need them. As users ask new questions over time, an “answer layer” builds up over a site or application, enabling future visitors to find answers easily without having to ask again.
Pacific Air Filtration provides new devices that improve indoor air quality while using less energy.
Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus.
PatientStream was a startup that provided a suite of cloud-based applications that increases hospital operating room efficiencies by replacing whiteboards with an automated, information exchange incorporating cutting-edge display technology. It is now inactive.
Rosetta@cloud was a startup that offered affordable, cloud-based pay-per-use molecular modeling and related services to the biotech and pharmaceutical industry. It is now inactive.
TaggPic Inc. geo-recognition technology analyzes photos based solely on visual features to recognize landmarks in digital photos, and the precise locations where the photos were captured.
TaggPic Inc. was acquired by Google in 2014.
Dato (formerly GraphLab) is a graph-based, high performance, distributed computation framework written in C++. While Dato was originally developed for machine learning tasks, it has found success in a broad range of data-mining tasks, out-performing other abstractions by orders of magnitude.
Synthetic Biologics (formerly Adeona Corp.) is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases.
Skytap gives software development and test teams a boost in agility with on-demand lab environments that are complete, collaborative and constraint-free. Skytap optimizes your global cloud infrastructure for increased dev/test efficiency and DevOps tool chain functionality.
- 1 of 4